Aurinia Pharmaceuticals (AUPH) Misses Q3 EPS by 1c, Misses on Revenue; Offers FY26 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| (NASDAQ: AUPH) | Delayed: 16.65 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.65 | 52 Week High | $5.69 | |||
| Open | $16.65 | 52 Week Low | $1.42 | |||
| Day High | $16.65 | P/E | N/A | |||
| Day Low | $16.65 | EPS | $0.00 | |||
| Volume | 2 | |||||
